ClinicalTrials.Veeva

Menu
B

Barbara Diaz Hernandez MD Research | San Juan, PR

Research site
(Unclaimed)

Site insights

Top conditions

Top treatments

Simufilam
KarXT
Centanafadine
SPN-812
Troriluzule

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

3 of 7 total trials
Locations recently updated

A Study to Evaluate KarXT as a Treatment for Psychosis Associated With Alzheimer's Disease (ADEPT-4)

The purpose of this study is to evaluate the safety and efficacy of KarXT in adult participants with mild to severe Alzheimer's Disease (AD) with mod...

Enrolling
Alzheimer Disease
Drug: Placebo
Drug: KarXT

To evaluate long-term safety exposure

Active, not recruiting
Attention Deficit/Hyperactivity Disorder
Drug: Centanafadine Hydrochloride

This is a Phase 3 global, multicenter, 52-week, open-label extension (OLE) rollover study for subjects completing study CN012-0026, CN012-0027, CN012...

Enrolling
Psychosis Associated With Alzheimer's Disease
Drug: KarXT
Drug: KarX-EC

Trial sponsors

C
Karuna Therapeutics logo
Biohaven logo
Otsuka logo
Supernus Pharmaceuticals logo

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems